Sodium glucose cotransporter 2 inhibition (SGLT2i) represents a promising new class of glucose lowering drugs but may not be recommended in type 2 diabetic patients with severe renal impairment. Here we evaluated the effects of dapagliflozin (DAPA) treatment in uni-nephrectomized Spontaneously Diabetic Torii (SDT) fatty rat. This novel hypertensive, obese, type 2 diabetic model, develops advanced renal complications and >50% glomerular filtration rate (GFR) decline within 10 weeks.
RESULTS
Sodium glucose cotransporter 2 inhibition (SGLT2i) represents a promising new class of glucose lowering drugs but may not be recommended in type 2 diabetic patients with severe renal impairment. Here we evaluated the effects of dapagliflozin (DAPA) treatment in uni-nephrectomized Spontaneously Diabetic Torii (SDT) fatty rat. This novel hypertensive, obese, type 2 diabetic model, develops advanced renal complications and >50% glomerular filtration rate (GFR) decline within 10 weeks.
BACKGROUND
Male, 6-week old SDT fatty rats underwent unilateral nephrectomy (Unx). After a 1-week recovery, rats were put on a salt-supplemented diet (Purina 5008 chow diet and drinking water supplemented with 0.3% salt) for 10 weeks. Rats were treated without or with DAPA 1mg/kg/day in the chow diet either upon diet start (10-week treatment) or after 3 weeks of diet to enhance kidney complications (7-week treatment). A group of control/sham operated rats was included to evaluate kidney complications induced by nephrectomy and salt supplementation.
Data are presented as mean±SEM. Statistical analysis was performed using either an unpaired, 2 tailed Student t-test, Mann-Whitney test or a 2-way ANOVA + Bonferroni post-test. A p<0.05 was considered significant.
METHODS
•Dapagliflozin for 10 weeks, but not 7 weeks, significantly prevents advanced renal complications in Unx SDT fatty rats.
•Long-term SGLT2i may be beneficial against kidney complications in the context of type 2 diabetes.
Dapagliflozin treatment for 7 weeks improves glycemic control but not kidney dysfunction in
Unx SDT fatty rat under 0.3% salt. 
